These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1556836)

  • 21. A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective?
    Pagano F; Bassi P; Milani C; Meneghini A; Maruzzi D; Garbeglio A
    J Urol; 1991 Jul; 146(1):32-5. PubMed ID: 2056600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravesical bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder tumors. Ablative and prophylactic effects of intravesical BCG on papillary tumors].
    Hagiwara M; Ohigashi T; Nakazono M; Asakura H; Tsukamoto T; Iigaya T; Yamamoto T; Shishido S; Hayashi A; Yamamoto H
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):521-6. PubMed ID: 3221605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intravesical BCG vaccine in bladder cancer].
    Beisland HO; Sander S
    Tidsskr Nor Laegeforen; 1989 Jun; 109(17-18):1891-2. PubMed ID: 2749672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
    Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K
    J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of superficial bladder tumors with intravesical BCG].
    Miskowiak J; Jensen JS
    Ugeskr Laeger; 1992 Mar; 154(10):640-3. PubMed ID: 1542971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
    Okuno H; Shirahase T; Kihara Y; Arai Y
    Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intravesical bacillus Calmette-Guerin instillation therapy of recurrent superficial bladder carcinomas resistant to intravesical anti-cancer chemotherapy].
    Takeuchi S; Kihara K; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1989 Apr; 35(4):577-81. PubMed ID: 2735262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacillus Calmette-Guérin treatment of 39 patients with superficial transitional cell carcinoma of the bladder.
    al Khalifa MA; Elfving P; Månsson W; Colleen S
    Scand J Urol Nephrol; 1991; 25(2):135-9. PubMed ID: 1871559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical bacillus Calmette-Guerin for superficial bladder cancer: experience with Danish 1331 strain.
    Kamat MR; Kulkarni JN; Tongaonkar HB; Dalal AV
    J Urol; 1994 Nov; 152(5 Pt 1):1424-8. PubMed ID: 7933175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
    Segawa N; Inamoto T; Nomi H; Ibuki N; Azuma H; Katsuoka Y
    Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
    Cervenakov I; Szoldova K; Mardiak J; Chovan D; Mala M; Slavov D
    Bratisl Lek Listy; 2000; 101(6):317-20. PubMed ID: 11039202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG.
    Orihuela E; Herr HW; Whitmore WF
    Urology; 1989 Nov; 34(5):231-7. PubMed ID: 2815442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
    Aso Y; Akaza H; Kameyama S; Niijima T
    Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
    Witjes JA; vd Meijden AP; Doesburg W; Debruyne FM
    Eur Urol; 1993; 23(3):366-70. PubMed ID: 8508889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinoma].
    Kudoh T; Motomura F; Saitoh F; Kogawa T; Suzuki T
    Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1857-60. PubMed ID: 2292818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of Tice strain BCG treatment in patients with transitional cell carcinoma in situ.
    Brosman S
    Prog Clin Biol Res; 1989; 310():193-205. PubMed ID: 2771993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.